glp 1 if not obese Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society GLP-1 has changed the conversation

Some of these include reducing the size of fat cells, lowering the accumulation of fat cells in the body, tackling insulin resistance, preserving muscle, and switching on the expression of the protein UCP1, which drives energy expenditure

[DOI] [PMC free article] [PubMed] [Google Scholar] 750.Hunter K., Holscher C

2024, doi: 10.1016/j.ajem.2024.05.018

GLP-1 Microdosing Chart & Schedule According to a 2,700-person real-world study presented at the 2025 European Congress on Obesity, participants achieved an average 16% weight loss over 64 weeks at microdose levels of semaglutide: Microdosing GLP-1 Weight Loss Results Microdose GLP-1 yields 5-10% body weight loss in year one versus 15-20% with full-dose treatment plans

Although digestive enzymes are produced in the body, they can also be taken in supplement form, either via prescription medication or over-the-counter supplements

From there, any future change is easy to spot and act on